Dag Linnarsson

Title: Dag Linnarsson: Innovator in Therapeutic Compounds

Introduction

Dag Linnarsson is a notable inventor based in Stocksund, Sweden. He has made significant contributions to the field of therapeutic compounds, holding a total of 3 patents. His work focuses on innovative methods for delivering gaseous nitric oxide and producing organic nitrites for pharmaceutical applications.

Latest Patents

Linnarsson's latest patents include compositions and methods for delivering gaseous nitric oxide (NO) to mammals for prophylactic or therapeutic purposes. This involves a composition capable of forming a reversible bond or association with NO. Additionally, he has developed methods for manufacturing therapeutic compounds and compositions. These methods utilize organic nitrites produced from mono/polyhydric alcohols or aldehyde- or ketone-derivatives after de-aeration, using NO gas. The resulting organic nitrites exhibit fewer impurities and improved storage stability compared to conventionally produced nitrites, making them suitable for various medical treatments.

Career Highlights

Throughout his career, Dag Linnarsson has worked with esteemed institutions, including the Karolinska Institutet, which is known for its medical research and innovation. His expertise in medical technology has allowed him to contribute significantly to advancements in therapeutic applications.

Collaborations

Linnarsson has collaborated with notable colleagues such as Lars Erik Gustafsson and Kristofer Nilsson. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.

Conclusion

Dag Linnarsson's contributions to the field of therapeutic compounds highlight his innovative spirit and dedication to improving medical treatments. His patents and collaborations reflect a commitment to advancing healthcare through scientific research and development.